• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS Pathog . N460S in PB2 and I163T in nucleoprotein synergistically enhance the viral replication and pathogenicity of influenza B virus

tetano

Editor, Senior Moderator
PLoS Pathog


. 2025 Sep 8;21(9):e1013463.
doi: 10.1371/journal.ppat.1013463. Online ahead of print. N460S in PB2 and I163T in nucleoprotein synergistically enhance the viral replication and pathogenicity of influenza B virus

Yang Wang[SUP] 1 2 3 [/SUP], Yu Gao[SUP] 1 [/SUP], Tianxin Ma[SUP] 1 [/SUP], Yuting Ye[SUP] 1 [/SUP], Chenyang Cao[SUP] 1 [/SUP], Binqian Zou[SUP] 1 [/SUP], Sulan Ye[SUP] 1 [/SUP], Qingsheng Huang[SUP] 1 [/SUP], Chunguang Yang[SUP] 1 [/SUP], Shengfeng Li[SUP] 1 [/SUP], Lixi Liang[SUP] 1 [/SUP], Hongxuan Zhou[SUP] 1 [/SUP], Zhiqi Zeng[SUP] 1 3 [/SUP], Zifeng Yang[SUP] 1 2 3 4 [/SUP], Weiqi Pan[SUP] 1 3 [/SUP]



Affiliations
Free article Abstract

Influenza B viruses (IBVs), though often overshadowed by influenza A viruses (IAVs), remain a significant global public health concern, particularly during seasons when they predominate. However, the molecular mechanisms underlying IBV pathogenicity remain largely unknown. In this study, we identified two amino acid substitutions, PB2-N460S and NP-I163T, from IBV clinical isolates with distinct replication and pathogenicity profiles. Using reverse genetics, we generated recombinant IBV viruses to evaluate the impact of these substitutions. In vitro and in vivo infections revealed that viral replication and pathogenicity were not significantly affected by either substitution alone but were substantially enhanced when both substitutions occurred together. Lung transcriptomics in mice infected with virus containing PB2-N460S/NP-I163T substitutions showed heightened immune activation. This was characterized by upregulated transcription of antiviral and immune-related genes, contributing to excessive inflammation and severe disease outcomes. Mechanistic investigations demonstrated that each substitution independently increased protein expression and strengthened PB2-NP interactions. However, only the combined presence of PB2-N460S and NP-I163T significantly enhanced polymerase activity. Structural modeling indicated that PB2-460 residue is positioned at the PB2-NP interface, while NP-163 site resides distally, suggesting an indirect functional interplay. These findings provide new insights into the molecular determinants of IBV pathogenesis, highlighting the synergistic effect of PB2-N460S and NP-I163T in enhancing viral fitness and worsening disease outcomes.


 
Back
Top